Cannabis stock Canopy rises after analyst says company will get boost from Canada's '2.0 market'
"The Canadian space is about to gain a fair amount of pricing power, in our view, as the 2.0 market opens up late this year," the analyst says.
"The Canadian space is about to gain a fair amount of pricing power, in our view, as the 2.0 market opens up late this year," the analyst says.
Guggenheim upgraded ride-hailing company Lyft to buy and established a $60 price target.
U.S. stock index futures edged higher on Monday as U.S. President Donald Trump moved to ease trade tensions with China, soothing investor nerves after intense feuding between the world's top two economies last week sent stocks into a tailspin.
Retailers are in for a weaker-than-expected holiday shopping season, according to Wells Fargo.
U.S. stocks opened higher on Monday, as President Donald Trump sought to ease trade tensions with China, calming investor nerves after intense feuding between the world's top two economies last week sent stocks into a tailspin.
New orders for key U.S.-made capital goods rose modestly in July while shipments fell by the most in nearly three years, pointing to continued weakness in business investment and a slowdown in economic growth early in the third quarter.
Yum Brands Inc said on Monday it will be testing Beyond Meat Inc's plant-based chicken nuggets and boneless wings at an Atlanta KFC restaurant, the latest fast-food chain trying new options to attract vegan diners.
A German court on Monday temporarily suspended a February decision by the cartel office to order Facebook to restrict its data collection practices in Germany.
KKR has become the biggest shareholder of German media group Axel Springer , paying 2.9 billion euros ($3.2 billion) for a 43.54% stake, the U.S. private equity firm said on Monday.
"The Canadian space is about to gain a fair amount of pricing power, in our view, as the 2.0 market opens up late this year," the analyst says.
Guggenheim upgrades ride-hailing company Lyft to buy and sets a $60 price target.
Amgen Inc will buy Celgene Corp's psoriasis drug Otezla for $13.4 billion in cash, clearing the way for Bristol-Myers Squibb to go ahead with its $74 billion deal for Celgene by the end of the year.
Wall Street rebounded on Monday after U.S. President Donald Trump sought to ease trade tensions with China, soothing investor nerves after an intense feud between the world's top two economies last week sent stocks into a tailspin.
Germany's cartel office said on Monday it would appeal a regional court decision to suspend restrictions it had placed on Facebook's data collection practices to the country's highest court.
"I'm aghast we trust the People's Republic of China more than we trust the White House," says CNBC's Jim Cramer.